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Abstract  
Medication non-adherence is a public health issue that stems across therapeutic areas and 
worsens over time. Research suggests that patients and providers have various mental models or 
understandings of non-adherence, and that each understanding calls for different interventions. 
This qualitative analysis identifies ten mental models of medication non-adherence through a 
critical literature review; and uses semi-structured stakeholder interviews to recommend 
appropriate mitigation strategies for each mental model. Strategies that tackle more than one 
mental model are expected to be most effective in reducing non-adherence amongst patients, as 
they cast a wider net. In the long-term, a screening tool aimed at identifying patients’ mental 
models could lead to more personalized, targeted, and effective interventions to increase 
adherence.  
 
Key words: medication adherence, medication compliance, mental model, chronic 
treatment, behavior change 
 
Introduction and Significance  
“Drugs don’t work in people who don’t take them” – C. Everett Koop1 
As echoed by the thirteenth surgeon general of the United States, medication non-
adherence often leads to worse health outcomes for patients. This public health issue corresponds 20	
to patients’ propensity to fill, refill and take their medication as prescribed at least 80% of the 
time, and extends across therapeutic areas. It is especially prevalent amongst patients with 
chronic therapies, as it concerns 50% of chronically ill people2 and 75% of all patients3. In 
particular, the World Health Organization determined that non-adherence to medication was the 
leading cause of failure to achieve blood pressure control among hypertensive patients4. 
Similarly, 25 to 50% of patients prescribed statins discontinue their treatment against their 
physician’s recommendation within one year, and up to 75% of them discontinue their treatment 
within two years5. In the US alone, one to two thirds of all hospital readmissions are the direct 
result of poor medication adherence6 and, along with other indirect costs of non-adherence, 
amount to between 100 and 300 billion dollars per year7,8. Moreover, increasing medication 
adherence amongst patients would improve their health outcomes more than any specific 
therapy 9 , and would result in positive social consequences such as higher workplace 
productivity10.  
The purpose of this study is to identify patients’ mental models (i.e. understandings) of 
medication adherence and the most prominent and effective mitigation strategies relevant to each 
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model. In particular, we have focused on mitigation strategies that seek to use and address, but 
not necessarily change, patients’ respective mental models, in order to improve adherence.  
 
Methods 
In order to identify the most prominent mental models of non-adherence and their 40	
associated mitigation strategies, we first conducted a literature review. Then, to assess the 
effectiveness of each mitigation strategy and the potential ways to combine them, we selected the 
most prominent organizations that conducted these interventions and reached out to stakeholders 
from each organization. It is important to note that the list of mitigation strategies mentioned 
below is not exhaustive, but instead represents a convenience sample of the most widespread and 
reachable stakeholders.  
Literature Review Methods 
Relevant literature was identified through the following PubMed search: (“medication 
adherence” OR “medication compliance”) AND “barriers” AND “chronic” AND “patient” AND 
(“understanding” OR “mental model” OR “perspective”) NOT “mental health” and limited to the 
past 10 years. Medication adherence and medication compliance were included in the PubMed 
search because they both relate to similar concepts, and mainly reflect a change in the healthcare 
field around perception of patients. In particular, “adherence” refers to patients’ choice to take 
their medication whereas “compliance” points to patients’ ability and propensity to follow 
healthcare providers’ directions. The change in terminology thus reflects the evolution of the 
perception of patient autonomy; and both terms correspond to similar behaviors.  
Moreover, “barriers” was included in the search, as mental models of non-adherence 
often manifest as explanations of barriers that prevent patients from taking their medication as 
prescribed; and “patient” was included to limit the search to patient related barriers to adherence. 
(“Understanding” or “mental model” or “perspective”) was included to limit the search to 60	
research articles that discuss not only the barriers to non-adherence but also the mental models or 
reasons behind them. Finally, “mental health” was excluded in order to avoid confusion with 
mental models; and the search was restricted to the past 10 years to obtain only the most relevant 
results. This search returned 35 results, and was manually complemented with recent pertinent 
publications from faculty members of the University of Pennsylvania.  
Interview Methods 
Semi-structured interviews of key experts in the field were then conducted to assess the 
initiatives mitigating medication non-adherence amongst patients and their corresponding mental 
models. In particular, the interview guide used (Appendix 1) consisted of open-ended questions 
about the key efforts mitigating medication non-adherence. We specifically surveyed a 
convenience sample of 14 interviewees (Appendix 2) from various organizations that tackle non-
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adherence, and sought to identify the mental models each effort was targeted towards. We further 
offered interviewees the opportunity to elaborate on each of the mental models they mentioned 
as well as on their organization’s corresponding efforts. The list of mental models identified 
through the literature review was given to 2 interviewees to prompt them to identify which 
model best corresponded to the mitigation efforts undertaken by their company. The other 
interviewees identified mental models of non-adherence and associated mitigation efforts 
without being prompted. 
Analysis Methods  
We used the mental models identified through the literature review to manually code the 80	
interviews and classify the mitigation strategies. Each strategy was associated with one or more 
mental model (Figure 2), and the different ways in which these models are tackled by each 
strategy are further discussed in the results section below.  
 
Results  
Firstly, the various mental models of non-adherence identified through the literature 
review and the stakeholder interviews are lack of affordability, lack of treatment coordination 
and continuity, lack of health literacy, lack of trust in healthcare providers, lack of involvement 
in medical decision making, forgetfulness, complexity of medication regimen, lack of social 
support, lack of visible effects of medication, and lack of motivation (Figure 1). The stakeholder 
interviewees (Appendix 2) also identified specific initiatives that tackle each of these mental 
models. In the discussion section below, we will first define each mental model of medication 
non-adherence, before diving into their associated efforts and inferring potential ways to 
combine them.  
Secondly, 13 out of 14 interviewees identified patient non-adherence as a public health 
issue that should be addressed, which further endorses our literature findings. The one 
interviewee who did not have any knowledge of this issue was a concierge physician, who spoke 
out of experience with his patients. This could be attributed to specific socio-economic 
conditions of his patient population. Moreover, as shown in Figure 1, lack of affordability and 
lack of trust in the healthcare team were deemed important by the highest number of 100	
stakeholders (6 out of 14), while complexity of medication regimen was only identified as a 
mental model of non-adherence by one interviewee. Lack of treatment coordination and 
continuity was also reported by 5 interviewees, who discussed various ways of addressing this 
mental model such as the addition of health assistants to the healthcare team, the use of 
concierge medicine, the use of telehealth and the emphasis on pharmacists’ role within the 
healthcare team.  
Similarly, lack of health literacy and lack of involvement in medical decision-making 
were each reported by 4 interviewees, while forgetfulness, lack of motivation and lack of visible 
	 4	
effects of medication were identified by 3 interviewees. Finally, only 2 of the interviewees 
thought that lack of social support was a valid mental model of non-adherence for patients 
(Figure 1).  
 
 
 
 
 
 
 
 
 120	
 
 
Figure 1: Number of interviewees Identifying Importance of Mental Model per Mental Model   
 
To further analyze this data, we have built a model relating the various mitigation 
strategies with their corresponding mental model(s) (Figure 2). The ways in which each 
mitigation strategy tackles its associated mental model(s) will be described in more detail in the 
discussion section below.  
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Figure 2: Mental Models and Associated Mitigation Strategies  
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Discussion  
Lack of Affordability and Access 
The lack of affordability and access mental model suggests that patients forgo taking 
their medications because they lack the financial or geographical means to purchase or access 
them. In particular, medication adherence can be negatively affected by drug prices, especially in 
countries where patient out of pocket costs (e.g. copays, coinsurances or full costs) are 
prohibitive for certain populations. Similarly, people who live in remote areas sometimes 
struggle to access pharmacies11. While this mental model of non-adherence relates to a structural 
issue, as opposed to patient-behavior concerns, it is very prevalent and has been targeted by a 
myriad of mitigation strategies such as insurance design initiatives (i.e. changes in copay and 
coinsurance levels), savings programs from pharmaceutical companies, and mail delivery 
pharmacies. It should also be noted that a holistic approach to care, including patients’ financial 
and geographical status, also indirectly tackles this model.  
Firstly, insurers structure their plans to increase preventative care use while also limiting 
healthcare services overuse. This is done by providing patients with low out of pocket costs for 
preventative services and higher copays or coinsurance for other services. While these efforts are 
costly in the short-term, as they increase preventative care use, they are expected to lead to 
important increases in adherence as well as to significant decreases in healthcare costs in the 
long run, mainly by decreasing the amount of therapeutic care use, especially hospital care.  180	
Secondly, various pharmaceutical companies, including Merck and Allergan, have started 
covering patients’ copays and coinsurances through savings programs and coupon giveaways. 
Craig Dashefsky12, in charge of the adherence group at Allergan, has noted that their savings 
program, which provides coupons to cover patients’ out-of-pocket costs, has had a significant 
positive impact on adherence. In fact, these efforts benefit both the patients, as they are given 
access to treatments virtually free of charge, and the pharmaceutical company as it increases its 
revenue. However, it is important to note that these coupons actually end up costing insurance 
companies: patients choose brand name drugs over generics, leaving insurance companies with 
hefty bills to pay13. Thus, this initiative creates competing forces: patients’ adherence to 
medication decreases associated healthcare costs while induced brand name preference increases 
those same costs.  
This mental model was further echoed by Mike Evans14, the vice president of clinical 
innovation and a clinical pharmacist at Geisinger. Evans argued that Geisinger patients faced 
four main barriers to medication adherence: affordability, strong side effects, lack of visible 
desirable effects and religious beliefs. Geisinger’s position as an integrated delivery network 
allows them to use a holistic approach to care and focus on each patient’s specific needs and 
barriers, including financial and geographical ones. For example, instead of following best 
practices guidelines for all patients, Geisinger seeks to first uncover patient characteristics, such 
as potential financial or geographical hurdles, and adapt their practices and prescriptions 
	 7	
accordingly. This patient-centric approach extends to Geisinger pharmacies, where pharmacists’ 200	
roles are emphasized: because of their frequent interactions with them, pharmacists are ideally 
positioned to deal with financial, geographical or other hurdles that patients might face. 
Pharmacists are able to build relationships with patients, have one-on-one interactions with them, 
and eventually address, report, and solve issues vis-à-vis adherence to medication.  
Finally, geographical hurdles are also addressed by integrated delivery systems. For 
instance, Geisinger provides patients with 90-day instead of 30-day refills to reduce the number 
of trips they take to the pharmacy. Similarly, mail delivery systems, which will be further 
discussed under the complexity of medication regimen model, overcome geographical hurdles by 
mailing medications to patients in daily packs. Both of these initiatives are expected to improve 
adherence for the concerned populations, as they effectively address patients’ lack of 
geographical access, but their effectiveness has yet to be formally established.  
While this model is definitely valid, it should be noted that it has been shown to be 
incomplete. A study from the New England Journal of Medicine (Choudhry et. al, 2011)15 
showed that even when medicines were free of charge and accessible at a local hospital, 
medication adherence rates only increased marginally. In particular, while there was a reported 
increase in medication adherence for the group of patients with free and accessible medication 
when compared with the control group, this increase was not enough to account for all of the 
non-adherence observed in patients. In other words, the patients with free access to medication 
had slightly higher levels of adherence (4 to 6 percentage points), but a significant number of 
them were still non-compliant. 220	
Lack of treatment coordination and continuity 
Healthcare is undeniably fragmented. Between 2000 and 2002, the average Medicare 
beneficiary saw a median of two primary care physicians and five specialists in addition to 
pharmacists and other healthcare workers16, thus demonstrating a lack of care continuity. This 
clear inefficiency leads to limited coordination between different clinicians, potentially 
contradicting advice as well as excessive choice, which reduce overall medication adherence. In 
order to address this mental model, efforts should be undertaken to coordinate and streamline 
care between all of the clinicians involved with each patient.  
These efforts are actually undertaken by various stakeholders: integrated healthcare 
systems are, by definition, able to standardize patient interactions with the system as a whole. In 
other words, when insurers, primary care physicians, pharmacists, nurses, specialist physicians 
and so on, all belong to the same organization, it is much easier for patients to directly access the 
care they need and get all of their questions answered at once1*.  
																																								 																				
1	*It is also important to note here that the fact that insurers are part of integrated health systems 
aligns their financial incentives with patients’ health outcomes, thus emphasizing the importance 
of medication adherence for these organizations.	
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Similarly, concierge physicians build personal relationships with their patients and 
become their point of entry to the healthcare system, which allows for continuous and 
coordinated care. Concierge physicians – who are different from healthcare concierges in that 
they are physicians who provide care at the patients’ request and not assistants there to help 
patients navigate the healthcare system – are thus able to tackle issues of continuity and 
coordination of care by being the patient’s healthcare point-person.  
Finally, the creation of health navigators or healthcare concierges has been particularly 240	
interesting and fruitful in coordinating care for patients. This initiative’s most prominent 
example is Accolade, a healthcare concierge company that connects patients with health 
assistants and leverages technology to drive meaningful, personalized engagement. Over the 
course of their interactions, Accolade Health Assistants® are often able to learn about patients' 
backgrounds, socio-economic and health statuses, and identify specific barriers to adherence and 
potential mental models of non-adherence. Emily Balmert17, a senior manager at Accolade, 
argued that Accolade’s role as a healthcare concierge not only helps patients navigate the 
intricacies of the healthcare system, but also navigate the contextual factors that impact patients 
seeking care, for example, finding a provider located along a local bus route to enable patients 
without cars to visit an in-network physician.  
Tom Spann’s assumptions when founding Accolade were that patients were disengaged 
because of a fragmented healthcare system, with too many options, poor service, and lack of 
personalization18. Thus, his company allows patients to bypass the complexities of the healthcare 
system and keep their respective data in easy to access and understand formats. Accolade data 
shows a 9% increase in prescription refills for their patients19, which suggests higher medication 
adherence for longer periods of time and validates the lack of treatment coordination and 
continuity mental model of medication non-adherence. However, this slight increase only 
accounts for some of the medication non-persistence in the US and around the world, which 
suggests that other mental models are at play for these patients.  
Moreover, it is important to note that Accolade’s initiatives are different from managed 260	
care networks’ efforts in that they connect each patient with a single health assistant, who then 
keeps track of their medical records and develops a personal relationship with them. On the other 
hand, managed care networks tend to have case managers, usually nurses*2, available to answer 
patients’ questions and help them navigate the healthcare system, but without case assignments. 
Thus, whenever a patient calls the insurance customer service line, they are matched up with a 
different case manager, which leads to care discontinuity. While these case managers do help 
patients access and navigate care, they do not tackle the lack of treatment coordination and 
continuity mental model of non-adherence. On the other hand, assigned health assistants per 
Accolade’s model, do so by assigning each patient a single health assistant. Both of these 
initiatives are expected to lead to increased patient adherence; however, according to this mental 
																																								 																				
*2	For example, UnitedHealth is in fact the largest employer of nurses in the United States. 	
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model, assigned health assistants should lead to a more drastic positive change in adherence than 
case managers.  
Lack of health literacy  
The lack of health literacy mental model touches more than one third of U.S. adults20 and 
corresponds to patients’ limited capacity to obtain, process and understand basic health 
information21. Health literacy is essential for patients to use preventative measures, learn about 
risk facts, make informed healthcare decisions, and follow relevant health recommendations (e.g. 
medication label directions)22,23. In particular, health literate patients tend to access and use 
healthcare services appropriately24 and adopt health-promoting behaviors such as medication 
adherence. On the other hand, low health literacy is correlated with infrequent health screenings, 280	
increased hospitalizations and mortality rates and poor adherence to medication25. Moreover, 
while education is sometimes used as a proxy for health literacy, the two are not directly 
correlated; and it is in fact health literacy that mediates improved outcomes for patients26. 
Patients of all ages, ethnicities, incomes and educational levels suffer from low literacy. It 
should be noted however that some population groups, including the elderly, people with less 
than a high school education, people living in poverty, racial and ethnic minorities and people 
with limited English proficiency, are more likely to be vulnerable to low health literacy than 
others. Currently, different initiatives were undertaken to address this mental model: Noora 
Health aims at educating patients indirectly through their families, Merck is using marketing 
campaigns to target and educate patient groups with low health literacy, and PatientsLikeMe uses 
online peer-to-peer interactions to empower patients to educate each other.  
Firstly, Noora Health educates patients and their family members during hospital 
downtime. In particular, nurses use hospital hallways and waiting rooms to provide personalized 
care-taking lessons to patients’ family members, adapted to their level of health literacy and 
education.  These trainings aim to educate patients’ families on the importance of adherence, and 
teach them practical skills and health facts around medications’ mechanisms of action. Noora 
Health’s services improve health literacy and focus on the importance of patients’ drugs and on 
regular medication-taking behavior. They use a “train-the-trainer” approach, i.e. they train nurses, 
who train family members, who train the patients, and so on. This preparation allows family 
members to become an in-house resource for patients, offering advice and information about 300	
their disease or treatment and highlighting the importance of medication, thus leading to 
improvements in adherence. 
 Moreover, most people inevitably interact with the healthcare system eventually, so 
Noora Health’s initiative in fact educates future patients such that they are health literate by the 
time they seek care for themselves. While this program results in drastic improvements in the 
form of reductions in post-surgical complications and 30-day readmissions27, its impact on 
medication adherence has not yet been measured. However, in light of the research done on the 
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positive effects of health literacy on medication adherence28,29, we believe that Noora Health’s 
approach is likely to increase adherence amongst current and future patients.  
Another initiative tackling this mental model is Merck’s marketing campaign, aimed at 
out of reach, low-literacy patients. This campaign consists of easy to read materials (flyers, 
pamphlets and such) that apply health literacy principles like bigger font size, spacing and 
simpler language, and recruits patients in out of reach areas such as senior centers. Merck’s 
health literacy team, led by Laurie Myers30, has developed best practices guidelines around 
direct-to-consumer material design to better communicate with low literacy patients and 
facilitate their engagement. These practices include labeling, packaging, and outreach efforts and 
have empowered patients and improved their adherence to and understanding of medication. 
While their effectiveness has not yet been determined, these practices are expected to lead to 
improved adherence and health outcomes31, as they would increase health literacy amongst the 
some of the most vulnerable populations.  320	
Moreover, Merck has also implemented physician-centric initiatives to tackle this mental 
model: the Teach-Back32 method for example consists of teaching physicians to ask patients to 
repeat their instructions before leaving the exam room. This is in contrast to asking whether the 
patient has any questions, as is conventionally done33. This method puts the burden of 
communication on the physicians, and thus increases the likelihood of uncovering 
misunderstandings and obtaining necessary clarifications. In fact, because of their lack of health 
literacy, many patients often do not recall their physician’s instructions; and amongst those who 
do recall, nearly half don’t remember the information correctly35. Merck’s Teach-Back technique 
serves to facilitate communication between healthcare providers and patients without burdening 
the patients. This is expected to lead to higher health literacy, and in turn, to higher adherence 
amongst patients.  
Finally, PatientsLikeMe is another innovative initiative that tackles this mental model of 
non-adherence, amongst others. It connects patients to one another and offers them a safe space 
to discuss their respective symptoms and experiences and build a community. PatientsLikeMe’s 
efforts will further be discussed under the lack of social support mental model, as that is the main 
mental model they touch on. However, it is important to note that PatientsLikeMe also 
significantly contributes to educating patients; creating trust and relationships between them and 
fostering shared decision-making. This online community provides patients with a resource to 
help answer the question: “Given my status or condition, what is the best outcome I can hope to 
achieve, and how do I get there?” Reported benefits of the community created on 340	
PatientsLikeMe include patients feeling that they knew more about their health and about the 
care they were administered, and asking their physician questions they would not have asked 
otherwise33. In fact, online communities like PatientsLikeMe not only provide information and 
opportunities to increase patients’ health literacy, but they also empower patients to feel more 
confident about their knowledge. These three initiatives are expected to increase patients’ health 
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literacy and adherence. However, it should be noted that there has yet to be a study comparing 
their relative effectiveness.  
 
Lack of trust in healthcare providers 
Trust in physicians is positively correlated with medication adherence rates amongst 
patients34 as well as with time spent with and number of questions asked by the physician during 
a consult35. These correlations are most likely due to physicians’ ability to engage patients in 
discussions around the importance of medication adherence and to recommend strategies to 
achieve positive health outcomes. However, clinicians spend an increasingly shorter time with 
their patients, thus making relationship building more challenging. This is especially the case in 
developed countries and urban areas where patients see more than 18 physicians on average over 
the course of their lifetime36; and where physicians are only able to allocate an average of 15 
minutes per patient visit37. In fact, in rural areas, where primary care providers are integral 
members of the community they treat, trust is not an issue. 
Various initiatives have been undertaken to foster trust between patients and providers: 360	
technology-based enterprises like Augmedix, improve physician-patient interactions, while 
integrated delivery networks such as Geisinger emphasize pharmacists’ roles as providers to 
increase contact with patients, and virtual forums, e.g. PatientsLikeMe, empower patients to 
reach out to their providers.  
Firstly, Augmedix re-purposes Google Glass technology to improve patient-physician 
quality of time by delegating record keeping. In particular, patient-physician relationships are 
recorded and sent to remote scribes in real time, which frees up to 15 hours of physicians’ 
schedules weekly38, allowing them to spend more time with each patient. This is expected to 
improve relationships and increase patient trust, in turn leading to higher rates of medication 
adherence. On the other hand, this increase in patient-physician time might also result in higher 
health literacy levels for patients, as they would have access to more time with their physician, 
which could reinforce trust and adherence. However, it should be noted that while Augmedix’ 
impact on patient satisfaction and adherence is expected to be significant, as the literature shows 
a direct link between quality of patient-physician time and positive outcomes39, it has yet to be 
measured.  
Secondly, integrated delivery networks such as Geisinger have pioneered a pharmacist-
centered initiative by training their pharmacists to identify “patient failures” and “medication 
failures” in adherence. “Patient failures” relate to barriers such as beliefs, costs and so on that are 
not related to the medication itself but rather to the patient, while “medication failures” 
correspond to the presence of strong side effects or lack of visible desirable effects of the 380	
medication. By making pharmacists central to care, these delivery systems give patients a go-to 
person to answer all of their questions and educate them, which, in turn is expected to foster trust 
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and eventually adherence. Multiple pharmacists have reported positive trends in trust and 
adherence, and the extent of these interventions’ effects is currently studied through randomized 
clinical trials40.   
Finally, online resources such as PatientsLikeMe indirectly foster patients’ trust in their 
providers. By having access to an online community to discuss their symptoms, treatments and 
provider recommendations, patients gain enough confidence and knowledge to ask questions 
during their interactions with physicians, pharmacists and other healthcare providers. This type 
of online resource affects other mental models (such as lack of health literacy, lack of social 
support, lack of visible effects of medication) that, in turn, have indirect repercussions on 
patients’ trust in their healthcare team, on adherence and on health outcomes in general. It should 
also be noted that while the literature suggests that these three initiatives could be effective in 
tackling this mental model and improving adherence, there is not enough information to compare 
their impact.  
Lack of involvement in medical decision-making  
Another mental model of medication non-adherence is patients’ lack of involvement in 
their medical decision-making. In particular, patients are sometimes excluded from the decision-
making process because of their lack of confidence, education, understanding, and health literacy 
or because of their physician’s perception and bias. Instead of deciding on a course of action 400	
with the help of their physicians, they sometimes end up having the decision prescribed to them. 
In fact, medical paternalism, i.e. the extent to which physicians assume a paternalistic attitude 
and disregard patient autonomy by not involving them in the decision-making process, is at odds 
with patient-centered care and often leads to lower rates of medication adherence41.  
This mental model is especially prevalent in low-health-literacy areas, which are usually 
developing countries and rural regions, and leads patients to perceive their physicians as 
omniscient. This might in turn make them more likely to accept physicians’ recommendations as 
unequivocal truths, but not necessarily more likely to follow them. Conversely, patients from 
areas with higher rates of health literacy and education are more likely to research their 
symptoms online or use decision-making aids before attending a consultation with a physician42. 
This, in turn, leads patients to ask more questions during their time with physicians, and have a 
better understanding of the course of treatment they will eventually follow, thus increasing their 
likelihood of adherence. In fact, patients’ lack of involvement is most often due to a combination 
of lack of background information, formality of their relationship with their physician43, and 
belief that they are not qualified to be part of the process. The more empowered patients feels, 
the more likely they are to participate in the decision making process and adhere to their 
medication.  
This mental model drove pharmaceutical companies, insurance companies and health 
professionals to create decision aids or quick-to-read informational documents to tackle 
medication non-adherence. Decision-making aids range from flyers and pamphlets to educational 420	
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videos and organized events, and aim to educate patients prior to their consultations with 
physicians, prompt them to ask more questions, and engage them in the decision-making process. 
However, while these tools were found to increase patient engagement and shared decision-
making between clinicians and patients, they were not always accessible. In fact, while many 
health decision aids around serious illnesses are available for clinicians, the reliable resources 
available to patients are scarce. Increasing their quantity and accessibility, and targeting them to 
the patients that need it most would lead to increased engagement and eventually to improved 
adherence.  
Moreover, it is important to note that some of the initiatives mentioned previously, such 
as Geisinger’s holistic approach to care, Accolade’s healthcare assistants, Noora Health’s 
educating services and PatientsLikeMe’s peer-to-peer education all indirectly impact patients’ 
involvement in medical decision making by empowering them through direct effects on other 
mental models (Figure 2). For example, Noora Health’s initiatives primarily tackle the lack of 
education and health literacy mental model; and when patients are educated, they feel more 
confident and qualified to participate in their medical decision-making. Similarly, Accolade’s 
healthcare assistants help patients navigate the healthcare system and provide them with tips and 
tools to learn more about their conditions, thus empowering them to participate in their medical 
decision-making process. Thus, because these initiatives are expected to increase adherence by 
directly or indirectly impacting various mental models, their relative effectiveness would be hard 
to establish. 440	
Forgetfulness  
Up to 60% of patients claim forgetfulness as their primary mental model of medication 
non-adherence44, thus making it one of the most commonly reported models. However, patients 
often identify this mental model as primordial in their non-adherence when they are in fact 
unaware of the real drivers of their lack of adherence. These drivers can be uncovered by 
studying medication-taking patterns amongst patients: forgetfulness implies patients not taking 
their medication in a random fashion; however, most patients (98%) actually show consistent 
patterns45, thus suggesting other underlying models.  
Various initiatives and resources such as reminder devices and personalized calls exist to 
tackle this mental model. Reminder devices range from standard daily pill boxes to pill bottle 
caps with timers displaying the time elapsed since the last medication was taken (TimerCap) and 
pill bottles with affixed strips with toggles that can be slid after each dose has been taken (Take-
n-Slide). While both TimerCap and Take-n-Slide claim to be proven ways of increasing 
medication adherence amongst patients, a research study46 has in fact shown the opposite: the 
odds of adherence are not substantially different between the patients using these devices, those 
using standard pill bottles, and those in the control group. Moreover, patients from different 
demographics responded differently to these tools. For example, men responded to Take-n-Slide 
better than women did, while patients who had higher rates of adherence before testing these 
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devices were more responsive to TimerCap but not to Take-n-Slide. This suggests that these 
reminder devices could be targeted to appropriate patient populations if an effective screening 460	
process is developed.  
On the other hand, there are various pieces of anecdotal evidence – both in the literature 
and mentioned by interviewees47 – claiming that reminder calls from health assistants or 
pharmacists are in fact effective. For example, Geisinger’s pharmacies, as well as other retail and 
integrated health system pharmacies, track patients’ refill patterns and issue reminder calls when 
refills are overdue. This has allowed providers to inquire on the reasons behind patients’ non-
adherence and work out potential medication issues with patients. Similarly, healthcare assistant 
services, such as Accolade mentioned earlier, play an important part in addressing this mental 
model of medication non-adherence. While reminder calls are not issued per se, health assistants 
will keep track of patients’ self-reported adherence by asking them about it regardless of the 
reason of their call. The impact of these initiatives cannot directly be compared to that of 
reminder devices, as the nature of their evidence is different (randomized control trial and 
anecdotal evidence, respectively). However, given that reminder devices do not seem to be 
effective, we believe that reminder calls and health assistants) are better suited to tackle this 
mental model of non-adherence.  
Complexity of medication regimen  
According to the complexity of medication regimen mental model, the more complex a 
patient’s medication regimen, the less likely they are to adhere to it. Even though only one 
interviewee identified this mental model as a barrier to adherence, the literature shows that this is 
a particularly prevalent model. In the US alone, 59% of the population is taking at least one 480	
prescription drug, and 15% of the population is taking five or more48. Complex medication 
regimens can be difficult to manage, understand and keep track of because there are many 
variables at play: with more than one drug, patients need to remember each medication’s 
schedule, as well as the mechanism of action and interactions between the different drugs. 
Moreover, patients sometimes have to refill each of their medications separately, which 
represents another barrier to adherence. Various initiatives are undertaken to alleviate this burden: 
pharmacies attempt to coordinate prescription refills for patients, mail delivery services provide 
patients with alternatives to conventional pharmacies, and educating services indirectly help 
patients make sense of each of their treatments.  
Firstly, Pillpack tackles this mental model of non-adherence by simplifying the day-to-
day hardships of adhering to more than one treatment and delivering patients’ prescriptions to 
their door in daily packs. In particular, Pillpack groups different regimens by time of day, as 
opposed to by treatment, thus leaving patients with one pack for “before breakfast”, one for 
“after lunch” and so on. This helps them overcome the hurdle of remembering and sorting 
through the different schedules of their medications. In fact, there is strong anecdotal evidence49 
that the convenience of this service increases medication adherence by eliminating activities that 
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patients do not enjoy doing (e.g. sorting medications and going to the pharmacy) and by breaking 
down medication adherence into daily goals, thus offering patients small wins every day. This 
positively reinforces adherence and encourages patients to continue following their complex 
regimens.  500	
Furthermore, educating services such as decision aids and trainings (as is offered by 
Noora Health and Merck’s literacy initiative, both mentioned above) also play a significant role 
in management of and adherence to complex medication regimens. By addressing the health 
literacy mental model, these initiatives indirectly impact patients’ understanding of their 
medication regimen as well as their ability and propensity to adhere to medication.  
Finally, insurers and pharmacies are attempting to streamline patients’ medication refills, 
i.e. allowing for 90-days refills instead of 30-day refills at a time and coordinating all refills. This 
would decrease the necessary patient trips to pharmacies, and would facilitate patient access to 
all of their required therapies, which, in turn, is expected to improve adherence. While all three 
of the initiatives mentioned here should be fruitful and lead to improved adherence, there is not 
enough data in the literature to compare their effectiveness.  
Lack of social support  
There is a strong positive correlation between social support and patient adherence to 
medication50. The literature reports that patients with weak structural or functional support 
systems, including low family cohesiveness and low emotional and practical support, are less 
likely to adhere to their medication regimens, especially in regions where familial life is 
emphasized51. Similarly, comfort and social support have been shown to increase medication 
adherence52. Moreover, it should be noted that while social support is usually accompanied by 
access to help in managing medication regimens, the emotional support itself is also instrumental 
in increasing patients’ medication adherence53.  520	
Two main initiatives tackle this mental model of non-adherence: online forums where 
patients suffering from similar conditions or symptoms are provided with a space to share 
information (such as PatientsLikeMe), and healthcare assistants (Accolade), both mentioned 
earlier. It should be noted that these two initiatives provide patients with significant support 
systems but also touch on more than this one mental model, and could thus have ripple effects.  
First, PatientsLikeMe offers virtual emotional and social support for patients by 
connecting them to “just-in-time, someone-like-me” peers54, i.e. others who might be suffering 
from similar symptoms or conditions, that can be relied upon to compare options and aid in 
decision making. These new connections alleviate patients’ fears and allow them to teach one 
another about drug’s mechanisms of action, potential ways to manage side effects or adherence 
techniques. This empowers patients to assume more responsibility for their care and thus 
decreases the burden on healthcare providers55. Participation in online communities has actually 
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been shown to heighten levels of emotional well being, perceived control over disease, and level 
of medical knowledge56,57. This, in turn, should lead to increased medication adherence.  
Moreover, this online tool allows patients to share their own data on medication 
effectiveness, dosage and side effects, as well data on their adherence to specific treatments58. 
For example, a patient is able to see how adherent others were, what kind of side effects they 
suffered from, how efficacious the drug was for them, and what they switched to after stopping 
that treatment. The availability and accessibility of this data is expected to drive adherence 
through peer approval, as echoed by various interviewees. In other words, this data could serve 540	
as a positive social pressure to drive patients to adhere to their medication59. On the other hand, 
if most patients did not adhere to a specific treatment, PatientsLikeMe data could also serve as a 
warning sign for pharmaceutical companies, healthcare providers and other patients. This tool 
not only empowers patients to learn from each other and develop a virtual social support group, 
but it also provides them with data from patient groups that could help them be more engaged in 
their diagnosis and treatment choice, and thus increase medication adherence according to the 
shared decision making mental model.   
Finally, healthcare assistants, such as those provided by Accolade, also tackle the social 
support mental model of medication non-adherence. While they do not form a community per se, 
they do provide patients with access to someone who knows about different aspects of their lives 
and is able to discuss not only medical issues, but also other social barriers or troubles that might 
be preventing patients from accessing care. Accolade has proven effective in improving 
medication adherence, but there is no data around whether this improvement is in fact due to a 
mitigation of the lack of social support mental model.  
No visible effects of medication  
Presence of visible effects of medication is another mental model of non-adherence: 
when side effects are very strong, and/or desirable effects are not noticeable, patients are more 
likely to discontinue their treatment regimen without consulting their healthcare providers60. 
When patients do not experience relief after taking their medication, or those with no symptoms 
to alleviate are less likely to take their medication diligently61. Similarly, the most common 560	
adherence-related patient complaints reported at Geisinger were lack of visible desirable effects 
of medication, and side effects of upset stomach and impotence.   
In fact, as mentioned previously, Geisinger’s Mike Evans17 noted that medication failure, 
defined as lack of desirable effects or presence of strong side effects, often leads to medication 
non-adherence62 and can be mitigated by emphasizing the role of the pharmacist as a medication 
point-person for patients. These pharmacist-patient interactions are necessary to provide patient-
centric care and consider patient related factors (e.g. effects of specific treatments on each patient) 
instead of always following best practices, as is currently done. In addition, pharmacists are the 
first healthcare providers to know when a patient is not adhering to medication, as they have 
access to patients’ last refill date and number of missed refills. This unique position empowers 
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pharmacists to start the conversation around adherence, find out whether the medication is a 
good pharmacological fit for the patient, and offer potential alternatives if necessary, which is 
expected to drive patient adherence.  
Moreover, virtual patient forums such as PatientsLikeMe, also mentioned previously, 
offer patients more information vis-à-vis dealing with strong side effects, and point them towards 
potentially better alternatives to their current treatment. By educating them on their options, 
these online resources empower patients to know whether and how side effects could be 
mitigated, as well as to find out about potential alternatives, hence fostering conversations with 
providers and indirectly driving medication adherence. It should however be noted that this 
initiative touches on many facets of adherence, and its effectiveness in tackling this mental 580	
model would be difficult to determine.  
Lack of motivation   
Finally, medication non-adherence can be due to a lack of motivation. Patients do not 
seem to be motivated by the possibility of future disease and thus tend to forgo taking their 
medication, especially in the case of preventative therapies. In fact, physicians have noted that 
patients tend to be more adherent to therapeutic treatments with immediate gratification in the 
form of health regain than to preventative treatments with delayed gratification in the form of a 
lack of potential future severe health episode. In other words, patients’ perceptions of treatments 
are dependent upon delay discounting effects, so preventative treatments appear less desirable 
because they only offer future rewards. For example, statins (cholesterol drugs), which prevent 
potential future heart-related episodes, are easily forgone, while therapeutic treatments such as 
antibiotics, which offer immediate relief, are more likely to be adhered to63. This is in fact 
confirmed by the neuroscience literature, which suggests that individuals tend to act in 
suboptimal manners when faced with longer time-delays64.  
Therefore, this mental model of medication non-adherence implies that offering financial 
or social incentives to patients would lead to increased adherence, especially for long-term 
preventative treatments. This theory has in fact been verified by various clinical trials65 where 
patients who are presented with social or financial (or both) incentives see consistent 
improvement in adherence versus control groups. In particular, these trials gave patients 
incentives for adherence that varied from lottery based monetary gains to peer mentorship or 600	
games played with the patients’ social entourage66, and found that the most effective incentives 
were small and regular monetary gains67. Moreover, these incentives have been proven effective 
not only in nudging patients towards adhering to their medication or to regular exercise, but also 
in nudging them towards healthier behaviors such as smoking cessation.   
Health systems such as Geisinger stand to gain the most from offering financial or social 
incentives. Because they are not only responsible for insuring patients but also for treating them, 
health systems stand to collect the long-term savings that these incentives lead to by preventing 
patient hospital readmissions and other health episodes, thus rendering them cost-effective67. 
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However, to our knowledge, these incentives have not yet been used alone, but have instead been 
part of broader efforts to increase adherence within health systems and insurance networks and 
their effectiveness is therefore difficult to estimate. For instance, in addition to financial 
incentives, Geisinger has implemented lower copays and coinsurances, surveys to gather 
information on patients’ treatment preferences, and periodic check-ins with patients to monitor 
adherence. All of these efforts combined have led to increased medication adherence amongst 
Geisinger’s patient population.  
  In summary, financial and social incentives couple short-term social and monetary 
rewards with long-term medication-taking behavior in order to nudge patients into taking their 
medications as prescribed. While preventative treatments are meant to avoid severe health 
episodes, their long-term nature is such that this reward is often discounted in patients’ minds, 
hence the effectiveness of financial and social immediate incentives demonstrated in clinical 620	
trials. This should be effective for most patients, as future gain – including health gain – 
discounting is very common amongst individuals.  
 
Limitations  
Our study has several limitations. Firstly, our interviewees are inherently biased: these 
stakeholders are involved with different initiatives, and are thus more likely to believe in their 
respective initiatives’ effectiveness. We selected these stakeholders mainly based on 
convenience, by first identifying their organizations and reaching out to various key members 
within that organization. Moreover, we only interviewed a small number of stakeholders (14). 
While they confirmed all mental models identified in the literature search, the number of 
interviewees who reported each model was different and most likely depended on these 
stakeholders’ respective positions and organizations. Some interviewees were able to identify 
multiple mental models and their associated mitigation strategies while others only identified one 
model, and sometimes did not have access to the appropriate information to confirm or deny 
certain models. Future research should focus on further investigating these trends and verifying 
the claims made by our interviewees.  
Secondly, while we do expect combinations of approaches to be most effective in 
reducing non-adherence, the data currently available only allows us to identify the need for more 
rigorous effectiveness data around these initiatives. Indeed, each of the mitigation strategies 
mentioned was either tested against a placebo control, or implemented on its own or with other 640	
initiatives. Thus, while the evidence presented suggests that these strategies are working to 
improve adherence, there is not enough data to compare their effectiveness.   
Thirdly, our data points to a significant need for the development of a diagnostic tool that 
would identify patients’ mental models of adherence. Future research should focus on 
developing a screening tool to delimitate the audiences that would be most responsive to each 
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mitigation strategy, as that would allow for personalized and targeted approaches to improve 
adherence. This tool could be used as described in Figure 3 to identify each patient’s mental 
model and match him or her with a personalized strategy to improve adherence.  
 
Conclusions and Next Steps 
Medication non-adherence is a significant issue that stems from various mental models, 
often leading to unnecessary adverse events and additional costs for patients. The most prevalent 
mental models of medication adherence reported by patients and physicians are lack of 
affordability, lack of treatment coordination and continuity, lack of health literacy, lack of trust 
in healthcare providers, lack of involvement in medical decision making, forgetfulness, 
complexity of medication regimen, lack of social support, lack of visible effects of medication, 
and lack of motivation. These models were discussed above, and the corresponding efforts to 
mitigate each of then were presented. So, how should these efforts be combined to obtain 
maximal effects on medication adherence?  
In order to construct the most appropriate combinations of initiatives for each patient, we 660	
must first identify non-adherent patients (Step 1, Figure 3). Managed care companies such as 
UnitedHealth have been using predictive analytics tools to foresee patients’ levels of adherence. 
These tools are proprietary algorithms that use retrospective patient data to predict their future 
behavior. For example, they allow managed care companies to identify the patients who are most 
at risk of non-adhering to their medication and send them targeted reminder texts or calls. 
Moreover, as stated by UnitedHealth, when used within one customer pool where most patients 
exhibit similar behavior (e.g. large employer groups), these algorithms are even able to predict 
patients’ behavior based on other individuals’ adherence patterns. However, this initiative is only 
able to detect whether a patient is non-adherent, and could not identify the corresponding 
underlying mental model. It therefore needs to be supplemented with a further screening process, 
as shown in Figure 3.  
In particular, we recommend that healthcare providers use predictive analytics tools in 
order to identify at risk patients, followed by surveys to match patients with their mental models 
and the mitigation strategies that are best fitted for them (Figure 3). Effective interventions will 
be those that identify and target a patient’s mental models through various complementary 
initiatives. Moreover, it should be noted that the more mental models a specific initiative impacts, 
the higher its expected effect would be on the concerned patients. For example, a patient who is 
non-adherent because of lack of health literacy and complexity of medication regimen will 
benefit most from connecting into virtual support groups, as this initiative targets both mental 
models (Figure 2).   680	
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Figure 3: Recommended Patient Flow Diagram 
 
If this patient screening process cannot be used for practical or feasibility reasons, then 
we would recommend that the most diversified mitigation strategies – those that touch on the 
highest number of mental models, such as holistic approach to care or health assistants, be 
implemented. Patients are more likely to benefit most from these strategies because they touch 
on multiple mental models, thus increasing the probability of tackling at least one mental model 
of adherence of any specific patient. While this solution is not ideal, as it is not personalized to 
each patient and it provides services that some patients may not need, it could in fact be an 
immediate way to tackle medication non-adherence amongst patients. Thus, implementing these 
broad mitigation strategies could be a short-term solution while more long-term personalized 
initiatives are designed.  
It is also important to note that using too many initiatives that tackle the same mental 
models might lead to diminishing marginal returns. For example, using a health assistant and a 
concierge physician would doubly tackle lack of treatment continuity and coordination, lack of 
education and health literacy, and lack of trust in the healthcare team mental models. Thus, using 
these mitigation strategies together would not in fact result in a much higher adherence than only 
using one of them. We would therefore recommend diversifying the mitigation strategies 
targeted at each patient such that they encompass various mental models and avoid overlap. 700	
In short, implementing a screening process such as the one described above would be 
ideal in the long term: patients could be first split into two groups depending on their levels of 
adherence, and then onto ten (or more, if more mental models are uncovered) depending on their 
	 21	
models of non-adherence (with some patients being in more than one group), and each patient 
would be given a specific combination of mitigation strategies that would be best for them. It is 
important to note here that adherence is a dynamic process, i.e. patients constantly fall in and out 
of adherence. This screening process would therefore have to be administered regularly by 
healthcare providers (Figure 3), in order to ensure that the mitigation strategies implemented are 
adequate for the patient at a specific point in time. This approach would allow for individualized 
solutions instead of widespread initiatives that only work on certain populations, and should thus 
lead to better results as well as lower overall healthcare costs. 
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Appendix 1 – Semi-Structured Interview Questionnaire (15 min +) 
Questionnaire Overview: (Data collection to be done over phone) 
Explanation of background – 2 min  
Questions – 12 min  
Optional Questions (if interview lasts more than 15min)  
Thank you & Conclusion – 1 min  720	
 
Explanation of background:  
I am writing a thesis at Wharton around medication adherence. In particular, I would like 
to find out the different efforts undertaken to solve medication adherence and the understandings 
of non-adherence they imply. For example, if you were to use a reminder device to solve your 
medication adherence that would mean that you believe you are not adherent because of 
forgetfulness. So, I seek to find out the different ways in which people understand and define 
adherence in order to come up with recommendations as to how to best tackle this issue and I 
would like to ask you some questions around the efforts and metrics around those efforts, that 
you or your organization are undertaking to tackle medication non-adherence.  
Questions 
1. Do you think medication non-adherence is an issue for your organization?  
a. If no, do you think medication adherence is an issue at all?  
i. If so, who do you think is concerned?  
 
b. If yes, why do you think that is?  
i. If needed, give examples of reasons (list of mental models) 
2. Do you think your organization is affecting patient medication adherence? If so, how? 
3. What efforts are you undertaking to mitigate non-adherence amongst patients?  
4. What efforts do you think have been working?  740	
5. Do you think these efforts have overall saved money to your organization?  
6. Is there anything you think I should know given the background of my project that I 
haven’t asked about? 
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Optional Questions 
 
1. Mainly for insurers/Health systems: How random does it seem that your patients forget 
their medicine? For example, do they not taking every Friday, or is the pattern truly 
random?  
 
2. Do patients only complain of forgetfulness, or is it accompanied by other worries?  
i. If so, what else do patients usually claim alongside forgetfulness?  
 
3. Are you tracking the evolution of adherence amongst your patients and how? 
i. Have you been able to quantify your efforts’ effects on adherence?  
ii. Why were these measures in particular chosen?   
 
4. Who do you think is the most crucial health provider in increasing medication adherence? 
i. Why? What aspect of their interactions with patients is most important? 
 760	
5. For integrated health systems: What do you think is the role of physicians in mitigating 
medication adherence?   
 
6. Mainly for insurers/Health systems/Physicians: How do patients on platinum/gold plans 
adhere vs patients on catastrophic plans? 
 
Thank you & Conclusion 
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Appendix 2: List of interviewees 
	
Type  Organization  Point Person  Role  Status  
Insurers  UnitedHealth Lambert van der Walde Executive Director Completed 
TeleHealth  
Clarion Telehealth  David Kimball Founder  Completed 
Geisinger  Janet Rushing  Head of Telehealth  Completed 
Health 
Systems 
Kaiser Anne-Maree Cantwell 
Senior 
Physician/Partner  Completed 
Geisinger   
Michael Evans  Pharmacist and Head of Research  Completed  
David Feinberg  CEO Put me in touch w/ Mike Evans 
Centers  
The institute for 
strategic threat 
analysis and response 
Harvey Rubin  Physician Completed 
Penn Diagnostic 
Center - Concierge 
Doc  
Lawrence Spitz Physician  Completed x2 
Healthcare 
Concierge  Accolade 
Emily Balmert  Senior Manager  Completed  
Peter Muller  Previous Director of HC Products 
Put me in touch w/ 
Emily Balmert 
Education  
PatientsLikeMe 
Paul Wicks  Head of Research  Completed  
Gayle Squires Business development 
Put me in touch w/ 
Paul Wicks 
Harvard  Niteesh Choudhry  Professor Completed 
Pharma/ 
Biotech  
Merck  
Jamie Rosati  Head of Adherence  Completed 
Laurie Myers Head of Literacy team  Completed 
Adam Schechter  CEO Put me in touch w/ Jamie Rosati 
Allergan  
Craig Dashefsky  Head of Adherence  
Completed 
Vijay Raghavan  On Adherence Team  
Brent Saunders CEO Put me in touch w/ Craig Dashefsky 
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